Bringing you a snapshot of the critical themes from Evaluate Vantage’s 2021 in Review, this infographic touches on key business development decisions and financing deals in the world of pharma, biotech and medtech. In short – 2021 was a year of mixed signals.
Share:
Bringing you a snapshot of the critical themes from Evaluate Vantage’s 2021 in Review, this infographic touches on key business development decisions and financing deals in the world of pharma, biotech and medtech.
In short – 2021 was a year of mixed signals.
By 2032, the global pharmaceutical market is forecast to reach almost $1.9tn. Inside the innovations, dealmaking, and portfolio strategies transforming the global biopharma pipeline.
